| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/17/2013 | CN101831369B Golden fungus gingko yellow wine, preparation method and efficacy thereof |
| 04/17/2013 | CN101822646B Fexofenadine hydrochloride orally disintegrating tablet and preparation method thereof |
| 04/17/2013 | CN101821392B RNA sequence motifs in the context of defined inter-nucleotide linkages inducing specific immune modulatory profiles |
| 04/17/2013 | CN101775078B Sea urchin content polysaccharide having anti-tumor and immunological activities and preparation method |
| 04/17/2013 | CN101766640B Preparation for panaxoside-Rd aqueous solution of propylene glycol and new application thereof in inflammation resistance, immune suppression and organ transplant rejection resistance |
| 04/17/2013 | CN101744792B Fluticasone propionate and salmeterol xinafoate compound dry powder inhalation and preparation technology thereof |
| 04/17/2013 | CN101709078B Immune-modulating peptide |
| 04/17/2013 | CN101589801B Process for manufacturing red ginseng honey slice |
| 04/17/2013 | CN101554206B Composite plant feed additive |
| 04/17/2013 | CN101466732B Collagen type IV-like immunoreactive peptide |
| 04/17/2013 | CN101371923B BAFF receptor (BCMA), an immunoregulatory agent |
| 04/17/2013 | CN101289510B 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420657 Pyrrolo[2,3-D]pyrimidines and use thereof as tyrosine kinase inhibitors |
| 04/16/2013 | US8420630 Pyrimidine derivatives |
| 04/16/2013 | US8420604 Method of drug formulation of compositions comprising crystalline microparticle surfaces |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | CA2628315C Compositions and methods for the detection of trypanosoma cruzi infection |
| 04/16/2013 | CA2545582C 5-(benz-(z)-ylidene)-thiazolidin-4-one derivatives as immunosuppressant agents |
| 04/16/2013 | CA2541090C Use of indole acetic acid or derivatives thereof to increase igf-1 serum levels |
| 04/16/2013 | CA2534579C Live attenuated bacterial vaccine |
| 04/16/2013 | CA2412504C Antigenic polypeptides |
| 04/11/2013 | WO2013052772A2 Anti-human sema4a antibodies useful to treat disease |
| 04/11/2013 | WO2013051928A1 Treatment of eosinophilic esophagitis |
| 04/11/2013 | WO2013050792A1 Bacterium for use as a probiotic for nutritional and medical applications |
| 04/11/2013 | WO2013049941A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |
| 04/11/2013 | WO2013022996A9 The utility of nematode small molecules |
| 04/11/2013 | WO2013022243A3 Novel biphenyl derivative or a pharmaceutically acceptable salt thereof, and pharmaceutical composition for preventing or treating inflammatory diseases or autoimmune diseases comprising same as an active ingredient |
| 04/11/2013 | WO2013019145A3 Biologically active product for use in veterinary medicine and animal husbandry, method for producing same and methods for enhancing viability, stimulating growth, stimulating immune function and enhancing the general non-specific resistance of livestock |
| 04/11/2013 | WO2013006548A3 Composition for use in treating and preventing inflammation related disorder |
| 04/11/2013 | WO2013002584A3 Combination of effective substances causing synergistic effects of multiple targeting and use thereof |
| 04/11/2013 | US20130089913 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 04/11/2013 | US20130089572 Partially Hydrolyzed Casein-Whey Nutritional Compositions For Reducing The Onset Of Allergies |
| 04/11/2013 | US20130089569 Recombinant mva capable of expressing structural hcv antigens |
| 04/11/2013 | US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 04/11/2013 | US20130089528 Compositions and methods for preserving insulin-producing cells and insulin production and treating diabetes |
| 04/11/2013 | CA2851244A1 Anti-human sema4a antibodies useful to treat disease |
| 04/11/2013 | CA2850932A1 Novel imidazole quinoline-based immune system modulators |
| 04/11/2013 | CA2850857A1 Liposome compositions comprising an adjuvant that activates or increases the activity of tlr2 and uses thereof |
| 04/11/2013 | CA2850000A1 Bacterium for use as a probiotic for nutritional and medical applications |
| 04/11/2013 | CA2849421A1 Malignant and non-malignant disease treatment with ras antagonists |
| 04/10/2013 | EP2578603A1 B cell activating factor antagonist and preparation method and use thereof |
| 04/10/2013 | EP2578587A1 Pyrazole derivatives |
| 04/10/2013 | EP2578585A1 Purinone derivative |
| 04/10/2013 | EP2578569A1 Heterocyclic ring compound and h1 receptor antagonist |
| 04/10/2013 | EP2578232A1 Treatment drug for autoimmune diseases and allergic diseases |
| 04/10/2013 | EP2578214A2 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin |
| 04/10/2013 | EP2575876A1 Multivalent synthetic nanocarrier vaccines |
| 04/10/2013 | EP2575871A1 Oral vaccine comprising an antigen and a toll-like receptor agonist |
| 04/10/2013 | EP2575857A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| 04/10/2013 | EP2575832A1 Pharmaceutical product comprising mite allergen extract(s) and a method for the manufacture thereof |
| 04/10/2013 | EP2575799A1 Methods for treating inflammatory autoimmune disorders |
| 04/10/2013 | EP2575773A2 Synthetic nanocarrier combination vaccines |
| 04/10/2013 | CN103038255A Novel anti-CD98 antibody and use thereof |
| 04/10/2013 | CN103038254A Antagonist anti-il-7 receptor antibodies and methods |
| 04/10/2013 | CN103037896A The N-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 04/10/2013 | CN103037877A Agent for controlling the increase and decrease of lactobacillus bifidus in colon |
| 04/10/2013 | CN103037876A Composition comprising probiotic bacteria for use in the treatment of immune disorders |
| 04/10/2013 | CN103031273A Tissue disintegration, cell adhesion, extraction and culture technology of adult stem cell |
| 04/10/2013 | CN103030678A Method for preparing rare ginsenoside from malonyl ginsenoside |
| 04/10/2013 | CN103028114A Nucleic acid vaccine, immunoadjuvant of nucleic acid vaccine, and preparation methods of nucleic acid vaccine and immunoadjuvan |
| 04/10/2013 | CN103028045A Externally applied traditional Chinese medicine composition for treating acute eczema and preparation method of traditional Chinese medicine composition |
| 04/10/2013 | CN103028037A Traditional Chinese medicine prescription for treating allergic rhinitis |
| 04/10/2013 | CN103028030A Traditional Chinese medicine decoction for treating allergic rhinitis and preparation method thereof |
| 04/10/2013 | CN103028001A Traditional Chinese medicine prescription for relieving asthma, relieving cough and resisting inflammatory, preparation method and application thereof |
| 04/10/2013 | CN103027963A Health care composition for relaxing bowels and improving organism immunity and preparation method |
| 04/10/2013 | CN103027943A Health-care medicated bath formula for children |
| 04/10/2013 | CN103027930A Biomass composition capable of forming and slowly releasing short-molecular polysaccharide, preparation method and preparation thereof |
| 04/10/2013 | CN103027927A Production process of transfer factor of spleen of laying hen |
| 04/10/2013 | CN103027914A New use of total alkaloids extracted from Fugu vermicularis, Rad tide and Saxidomus giganteus |
| 04/10/2013 | CN103027906A Application of arctigenin in treating anemia |
| 04/10/2013 | CN102408973B Rhizoma polygonati health wine and preparation method thereof |
| 04/10/2013 | CN102308898B Medicinal fresh Chinese herb tea containing Chimonanthus fragrans, and preparation method and usage thereof |
| 04/10/2013 | CN102295709B Ganoderma lucidum polysaccharide with light color and high molecular weight, and preparation method thereof |
| 04/10/2013 | CN102078621B Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 04/10/2013 | CN102002493B Application of small RNA-326 in preparation of medicament |
| 04/10/2013 | CN101897964B Medicament for preventing autoimmune disease |
| 04/10/2013 | CN101817813B Crystal IV of 3-(substituted dihydroisoindolinone-2-yl)-2,6-piperidinediketone and medicinal composite thereof |
| 04/10/2013 | CN101712679B Acylamide class compound, medicine composition, preparation method and application thereof |
| 04/10/2013 | CN101693103B Improvement of completeness of intestinal barrier |
| 04/10/2013 | CN101318017B Vaccine for preventing and/or treating allergic asthma |
| 04/09/2013 | US8415329 Thermoprotected compositions and process for terminal steam sterilization of microparticle preparations |
| 04/09/2013 | US8415152 Therapeutical composition containing dentritic cells and use thereof |
| 04/09/2013 | US8414916 Chewable soft capsule |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414894 Human antibodies that bind human TNFα and methods of using same |
| 04/09/2013 | CA2588881C Potentiators of glutamate receptors |
| 04/09/2013 | CA2451116C Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsaturated fatty acids from microbes, genetically modified plant seeds and marine organisms |
| 04/09/2013 | CA2383470C Inhibition of secretion from non-neuronal cells |
| 04/09/2013 | CA2361658C T helper cell epitopes |
| 04/09/2013 | CA2241373C Compositions and methods for t-cell activation comprising gm-csf and tumor antigen fusion proteins |
| 04/04/2013 | WO2013049539A1 A method of blocking or trapping allergens |
| 04/04/2013 | WO2013049362A2 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 04/04/2013 | WO2013048226A1 Immunomodulator metallopeptides (immps) and compositions containing same |
| 04/04/2013 | WO2013047889A1 Pharmaceutical composition for treating autoimmune diseases |
| 04/04/2013 | WO2013047844A1 Ngf aptamer and application thereof |
| 04/04/2013 | WO2013047752A1 Antigen-binding molecule for promoting loss of antigens |
| 04/04/2013 | WO2013047725A1 Drug for the treatment of allergic rhinitis comprising pgd2 antagonist and histamine antagonist |
| 04/04/2013 | WO2013046722A1 Ion concentration-dependent binding molecule library |